CRP and psoriatic arthritis: For Tumour Necrosis Factor alpha inhibitors (TNFi), many different clinical variables (Health Assessment Questionnaire (HAQ), C-reactive Protein (CRP), Body Mass Index (BMI), Disease Activity Index in Psoriatic Arthritis (DAPSA), gender, age, disease duration, etc.)have been reported as a predictor of response.